Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1987-01-16
1991-07-16
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
424 93, 424582, 4351723, 4352402, 800 2, 935 62, A61K 3500, C12N 1500, C12N 500
Patent
active
050324071
ABSTRACT:
This invention is directed to a method for the preparation of carrier cells capable of delivering exogenous genetic material to a particular tissue of the body by means of embryonic cells competent to develop into that tissue, and essentially only that tissue, said cells bearing the exogenous genetic material. The preferred carrier cells are mesodermal cells of the yolk sac or embryonic forebrain or midbrain cells, and the desired genetic material is preferably introduced into the cells by in vitro transformation with an amphotrophic retroviral vector.
REFERENCES:
patent: 4497796 (1985-02-01), Salser et al.
Anderson, French W., "Prospects for Human Gene Therapy", Science 226:401 (1984).
"Differential Susceptibility of Mouse Trophoblast and Embryonic Tissue to Immune Cell Lysis", Jenkinson and Billington, Transplantation, 18:286-88 (1974).
"Transplantation of Fetal Hematopoietic Stem Cells in Utero: The Creation of Hamatopoietic Chimeras", Flake, et al., Science, 233:776-78 (1986).
"Introduction of a Selectable Gene into Primitive Stem Cells Capable of Long-Term Reconstitution of the Hemopoietic System of W/W.sup.v Mice", Dick, et al., Cell, 42:71-79 (1985).
"Retrovirus Transfer of a Bacterial Gene into Mouse Haematopoietic Progenitor Cells", Joyner, et al., Nature, 305:556-559 (1983).
Studies on the Immunobiology of Mouse Fetal Membranes: "The Effect of Cell-Mediated Immunity of Yolk Sac Cells in Vitro", J. Reprod. Fert., 41:403-412 (1974).
Billington and Jenkinson, "Antigen Expression During Early Mouse Development", Balls and Wild, The Early Development of Mammals, 219-232, (1975).
Ritter, "Early Differentiation of the Lymphoid System", Balls and Wild, The Early Development of Mammals, 359-372 (1975).
"Factors Regulating Yolk Sac Hematopoiesis in Diffusion Chambers: Various Types of Sera, Cyclophosphamide, Irradiation and Long-Term Culture", Weinberg and Stohlman, Jr., Exp. Hematol., 5:374-384 (1977).
"An in vitro Morphological Study of the Mouse Visceral Yolk Sac and Possible Yolk Sac Immunocyte Precursors", Cell Tissue Res., 113-119 (1977).
"Hemopoiesis and Blood Vessels in Human Yolk Sac", Hesseldahl and Larsen, Acta. Anat. 78:271-291 (1971).
"Initial Growth of Transplanted E11 Fetal Cortex and Spinal Cord in Adult Rat Spinal Cord", Bernstein, et al., Brain Research 343:336-345 (1985).
"Establishment in Culture of Pluripotential Cells from Mouse Embryos", Evans and Kaufman, et al., Nature, 292:154-156 (1981).
"Some Aspects of Tissue Interaction in Vitro", Auerbachm Epithelical-Mesenchymal Interactions, Chap. 13, pp. 200-7 (1968).
"Evidence for the Time of Appearance of H-2 Antigens in Mouse Development," Patthey and Edidin, Transplantation, 15:211-214 (1973).
"Demonstration of Permanent Factor-Dependent Multipotential (Erythroid/Neutrophil/Basophil) Hematopoietic Progenitor Cell Lines", Greenberger, et al., P.N.A.S. (U.S.A.), 80:2931-35 (1983).
"Introduction of New Genetic Material into Pluripotent Haematopoietic Stem Cells of the Mouse", Williams, et al., Nature, 310:476-80 (1984).
"Gene Expression in Mice After High Efficiency Retroviral-Mediated Gene Transfer", Eglitis, et al., Science 230;1395-98 (1985).
"Amphotropic Retrovirus Vector Transfer of the v-ras Oncogene to Human Hematopoietic and Stromal Cells in Continuous Bone Marrow Cultures", Rothstein, et al., Blood, 65:744-752 (1985).
"Fetal Liver, A Source for Hemopoietic Reconstitution without GHVD?", Heit, et al., Biology of Bone Marrow Transplantation, 507-517 (Academic Press; 1980).
"Fetal Bone Grafts do not Elicit Allograft Rejection Because of Protecting Anti-Ia Alloantibodies", Segal, et al., Transplantation, 28:88-95 (1979).
"Transgenesis by Means of Blastocyst-Derived Embryonic Stem Cell Lines", Gossler et al., PNAS (U.S.A.) 83:9065-69 (Dec. 1986).
"Totipotent Hematopoietic Stem Cells: Normal Self-Renewal and Differentiation after Transplantation between Mouse Fetuses", Fleischman, et al., Cell, 30:351-59 (1982).
"Murine Yolk Sac Hematopoiesis Studied with the Diffusion Chamber Technique" Symann, et al., Exp. Hematol., 6:749-59 (1978).
Lovell-Badge et al., Cold Spring Harbor Symp. Quant. Biol., vol. L, pp. 707-712 (1985), Cold Spring Harbor Lab., New York.
Gossler et al., Proc. Natl. Acad. Sci. 83:9065-9 (1986).
Kuehn et al., Nature 326:295 (1987).
Corn Barbara J.
Reed Michael A.
Wagner Thomas E.
Chambers Jasemine C.
Cooper Iver P.
Ohio University Edison Animal Biotechnology Center
Weimar Elizabeth C.
LandOfFree
Gene transfer using transformed, neodetermined, embryonic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene transfer using transformed, neodetermined, embryonic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene transfer using transformed, neodetermined, embryonic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-130340